Comparison of the effects on glycaemic control and β‐cell function in newly diagnosed type 2 diabetes patients of treatment with exenatide, insulin or pioglitazone: a multicentre randomized parallel‐group trial (the <scp>CONFIDENCE</scp> study)Wen Xu, Jianping Weng, Lixin Guo et al.|Journal of Internal Medicine|2014Cited by 59